Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Yahoo Finance Results

    2. Mallinckrodt (MNK) Tops Q2 Earnings, Generics Segment Weak

      Zacks via Yahoo FinanceAug 08 17:50 PM

      Mallinckrodt Public Limited Company MNK reported second-quarter 2017 results wherein earnings beat expectations but sales missed the same. The company reported adjusted earnings of $1.85 ...

    3. Mallinckrodt (MNK) Tops Q2 Earnings, Misses on Sales

      Zacks via Yahoo FinanceAug 08 10:38 AM

      Ireland-based Mallinckrodt Public Limited Company MNK focuses on developing treatments for autoimmune and rare diseases (including neurology, rheumatology, nephrology and pulmonology) ...

    4. Mallinckrodt Plc NYSE:MNK Score: Neutral (60) 2 days at current score. Downgraded from Positive on August 9th 2017 View full report here! Summary This company ranked neutral compared ...

    5. Why Mallinckrodt (MNK) Might Surprise This Earnings Season

      Zacks via Yahoo FinanceAug 04 12:37 PM

      Investors are always looking for stocks that are poised to beat at earnings season and Mallinckrodt plc MNK may be one such company. The firm has earnings coming up pretty soon, and events ...

    6. Mallinckrodt (MNK) Looks Strong on Acthar, Generics Weak

      Zacks via Yahoo FinanceAug 15 13:52 PM

      We issued an updated report on Mallinckrodt plc MNK on Aug 14. Mallinckrodt develops, manufactures, markets and distributes branded and generic specialty pharmaceutical and biopharmaceutical ...

    7. STAINES-UPON-THAMES, United Kingdom, Aug. 7, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (MNK), a leading global specialty pharmaceutical company, will present on Thursday, Sept ...

    8. Quote Mallinckrodt plc MNK is set to report second-quarter 2017 results. Mallinckrodt has delivered an average positive earnings surprise of 5.27% in the trailing four quarters. Mallinckrodt ...

    9. ...acquisition to adjusted diluted earnings per share of $0.15 to $0.20 in 2017; dilution modestly higher in 2018 -- STAINES-UPON-THAMES, United Kingdom, Aug. 4, 2017 /PR Newswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, and InfaCare Pharmaceutical Corporation today announced that they have entered into an agreement under which Mallinckrodt will acquire InfaCare, a privately held specialty pharmaceutical...

    10. Unless otherwise noted, all comparisons are to the prior year comparable three-month and six-month periods ended June 24, 2016...

    11. STAINES-UPON-THAMES, United Kingdom, Aug. 15, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (MNK), a leading global specialty pharmaceutical company, will present on Tuesday, Sept ...

    1. Ads
      related to $MNK